Reposted by Dana-Farber's AYA Sarcoma Program
In a recent publication in the Journal of Clinical Oncology, @danafarber.bsky.social researchers found that a blood test measuring tumor DNA could help identify patients with Ewing sarcoma at higher risk of relapse, a potential tool for guiding future treatment decisions.
➡️bit.ly/4heEyW1